| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |